Cockrell Group
Long only, deep value, value, growth at reasonable price

TherapeuticsMD: Advancing Women's Health

Therapeutics MD (NYSEMKT: TXMD) has uniquely positioned itself to address a key issue in hormone therapy (NYSE:HT). The issue is this: in hormone therapy, monotherapies, or drugs that address a single hormonal issue, do not work well, because if a drug suppresses one problem hormone, the levels of another problem hormone go up. So, this creates a need for developing combination therapies in the HT market. However, the only FDA approved drugs available in the HT market are monotherapeutic bio-identicals. So, doctors are being forced to send women to compounding pharmacies, where non-FDA approved synthetic drugs are compounded to create over-the-counter hormone therapies. These therapies are extremely harmful, and can lead to severe side effects like cancer....

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details